BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25843731)

  • 1. Prevention of human papillomavirus-associated cancers.
    Dillner J
    Semin Oncol; 2015 Apr; 42(2):272-83. PubMed ID: 25843731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
    Smelov V; Elfström KM; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
    Int J Cancer; 2015 Mar; 136(5):1171-80. PubMed ID: 25043476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are 20 human papillomavirus types causing cervical cancer?
    Arbyn M; Tommasino M; Depuydt C; Dillner J
    J Pathol; 2014 Dec; 234(4):431-5. PubMed ID: 25124771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HPV and cancer].
    Spano JP; Marcelin AG; Carcelin G
    Bull Cancer; 2005 Jan; 92(1):59-64. PubMed ID: 15689325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-beyond cervical cancer (online resource center).
    Alexander KA; Giuliano AR
    Am J Med; 2012 Jul; 125(7):S1. PubMed ID: 22727241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
    Gheit T; Vaccarella S; Schmitt M; Pawlita M; Franceschi S; Sankaranarayanan R; Sylla BS; Tommasino M; Gangane N
    Vaccine; 2009 Jan; 27(5):636-9. PubMed ID: 19056450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J; Luckett R; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):493-506. PubMed ID: 30041818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
    Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.